It can be used for diagnosis and evaluation of neuropsychiatric diseases such as schizophrenia, mood disorders, cerebral palsy and traumatic brain injury.[27,28] This study retrospectively analyzed serum S100B protein expression in 46 patients in the CwG group and compared the results to those of 35 patients in FS group. This evidence concerns the gene S100B and mood disorder.